PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 114 filers reported holding PROVENTION BIO INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,257,241 | +53.9% | 176,649 | -32.5% | 0.00% | +100.0% |
| Q4 2022 | $2,765,714 | +5218.7% | 261,657 | +2174.5% | 0.00% | – |
| Q3 2022 | $52,000 | -98.2% | 11,504 | -97.1% | 0.00% | -100.0% |
| Q1 2022 | $2,863,000 | +280.7% | 391,061 | +192.0% | 0.00% | – |
| Q4 2021 | $752,000 | -36.9% | 133,932 | -28.0% | 0.00% | – |
| Q3 2021 | $1,191,000 | -59.0% | 186,110 | -46.0% | 0.00% | – |
| Q2 2021 | $2,906,000 | +742.3% | 344,805 | +947.8% | 0.00% | – |
| Q1 2021 | $345,000 | +13.5% | 32,909 | +83.6% | 0.00% | – |
| Q4 2020 | $304,000 | -77.2% | 17,924 | -82.7% | 0.00% | -100.0% |
| Q3 2020 | $1,333,000 | -48.8% | 103,857 | -43.8% | 0.00% | 0.0% |
| Q2 2020 | $2,605,000 | +310.9% | 184,639 | +168.0% | 0.00% | 0.0% |
| Q1 2020 | $634,000 | – | 68,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |